[en] The human IGF2 gene belongs to a group of imprinted genes clustered on the short arm of chromosome 11, band p15.5. It contains 9 exons and spans over 30 kb. IGF2 mRNA overexpression has been reported in human tumours and in some inherited growth disorders. It was recently demonstrated that IGF2 mRNA overexpression contributes to tumour progression and that loss of parental imprinting as well as altered transcription factors are contributing to this overexpression. We have reported structural alterations in the 3' region of the IGF2 gene in two colorectal tumours that overexpressed the IGF2 transcript by 200- and 800-fold. We cloned by the vectorette-PCR strategy, genomic DNA fragments containing the breakpoints from these tumours. The sequencing of these fragments positioned the breakpoint 2 kb downstream the IGF2 gene in one tumour, and in exon 9 in the second. Both breakpoints occurred in regions containing repetitive elements: a TGGA repeat we have identified downstream the gene, and the (CA)n repetition in exon 9. We hypothesize that a negative regulatory element, located downstream the IGF2 gene, has been deleted following these structural alterations and leads to IGF2 gene overexpression.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Hodzic, D.
Frey, B.
Delneuville, Delphine ; Université de Liège - ULiège > Anatomie et cytologie pathologiques
Scarcez, T.
Grooteclaes, M.
Winkler, Rose ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques
Language :
English
Title :
Cloning of Breakpoints in and Downstream the Igf2 Gene That Are Associated with Overexpression of Igf2 Transcripts in Colorectal Tumours
Giannoukalis N, Deal C, Paquette J, Goodyear CG and Polychronakos C. (1993). Nature Genet., 4, 98-101.
Gicquel C. Bertagna X and Le Bouc Y. (1995). Eur. J. Endocrinol., 133, 133-144.
Humbel RE. (1990). Eur. J. Biochem., 190, 445-462.
Irminger JC, Schoenle EJ, Briner J and Humbel RE. (1989). Eur. J. Pediatr., 148, 620-623.
Ishida S, Noda M, Kuzuya N, Kubo F, Yamada S, Yamanka T, Isozaki O, Hizuka N and Kanazawa Y. (1995). Internal Med., 34, 1201-1206.
Jones JI and Clemmons DR. (1995). Endocrine Rev., 16, 3-34.
Karnik P, Chen P, Paris M, Yeger H and Williams BRG. (1998). Oncegene, 17, 237-240.
Lambert S, Vivario J, Boniver J and Gol-Winkler R. (1990). Int. J. Cancer, 46, 405-410.
Mannens M, Hoovers JMN, Redeker E, Verjaal M, Feinberg AP, Little P, Boavida M, Coad N, Steenman M, Bliek J, Niikawa N, Tonoki H, Nakamura Y, de Boer EG, Slater RM, John R, Cowell JK, Junien C, Henry I, Tommerup N, Weksberg R, Pueschel SM, Leschot NJ and Westerveld A. (1994). Eur. J. Hum. Genet., 2, 3-23.
Minniti CP and Helman I.J. (1994). Current Directions in Growth Factors Research. Leroith D and Raizada MK. (eds). Plenum Press: New York, pp. 327-345.
Rainier S, Johnn LA, Dobry CJ, Ping AJ, Grundy PE and Feinberg AP. (1993). Nature, 362, 747-749.
Reeve AE, Eccles MR, Wilkins RJ, Bell GI and Millow LJ. (1985). Nature, 317, 258-260.
Rogler CE, Yang D, Rossetti L, Donohe J, Alt E, Chang CJ, Rosenfeld R, Neely K and Hintz R. (1994). J. Biol. Chem., 269, 13779-13784.
Schneid H, Seurin D, Noguiez P and Le Bouc Y. (1992). Growth Regul., 2, 45-54.
Sun F-L. Dean WL, Kelsey G, Allen ND and Reik W. (1997). Nature, 389, 809-815.
Sussenbach JS, Rodenburg RJT, Scheper W and Holthuizen P. (1994). Current Directions in Insulin-like Growth Factor Research. Leroith D and Raizada MK. (eds). New York, pp. 63-71.
Toretsky JA and Helman LJ. (1996). J. Endocrinol., 149, 367-372.
Winqvist R, Hampton GM, Mannermaa A, Blanco G, Alavaikko M, Kiviniemi H, Taskinen PJ, Evans GA, Wright FA, Newsham I and Cavenee WK. (1995). Cancer Res., 55, 2660-2664.